A Call for Quality: Substandard Research in Male Sexual and Reproductive Medicine During the COVID-19 Pandemic - PubMed (original) (raw)

A Call for Quality: Substandard Research in Male Sexual and Reproductive Medicine During the COVID-19 Pandemic

Alexander W Pastuszak et al. J Sex Med. 2022 Jan.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Figure 1

COVID-19 related publications in Male Sexual and Reproductive Medicine between December, 2019-June, 2021 (n = 395).

References

    1. Chen Q., Allot A., Lu Z. Keep up with the latest coronavirus research. Nature. 2020;579:193. -PubMed
    1. Pundi K., Perino A.C., Harrington R.A., et al. Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov. JAMA internal medicine. 2020;180:1398–1400. -PMC -PubMed
    1. Fraser N., Brierley L., Dey G., et al. The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape. PLoS biology. 2021;19 -PMC -PubMed
    1. Zdravkovic M., Berger-Estilita J., Zdravkovic B., et al. Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study. PloS one. 2020;15 -PMC -PubMed
    1. Baker N., Van Noorden R. Coronapod: The Surgisphere scandal that rocked coronavirus drug research. Nature. 2020 doi: 10.1038/d41586-020-01790-y. -DOI -PubMed

MeSH terms

LinkOut - more resources